The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 30, 2011
Filed:
Apr. 02, 2007
Anna M. Ericsson, Shrewsbury, MA (US);
Andrew Burchat, Shrewsbury, MA (US);
Kristine E. Frank, Worcester, MA (US);
David J. Calderwood, Framingham, MA (US);
Lily K. Abbott, Brighton, MA (US);
Maria A. Argiriadi, Wayland, MA (US);
David W. Borhani, Worcester, MA (US);
Kevin P. Cusack, Holden, MA (US);
Richard W. Dixon, Jefferson, MA (US);
Thomas D. Gordon, Medway, MA (US);
Kelly D. Mullen, Charlton, MA (US);
Robert V. Talanian, Harvard, MA (US);
Xiaoyun Wu, Westborough, MA (US);
Xiaolei Zhang, Ashland, MA (US);
LU Wang, Northborough, MA (US);
Biqin LI, Northborough, MA (US);
Claude E. Barberis, Hillsborough, NJ (US);
Neil Wishart, Jefferson, MA (US);
Anna M. Ericsson, Shrewsbury, MA (US);
Andrew Burchat, Shrewsbury, MA (US);
Kristine E. Frank, Worcester, MA (US);
David J. Calderwood, Framingham, MA (US);
Lily K. Abbott, Brighton, MA (US);
Maria A. Argiriadi, Wayland, MA (US);
David W. Borhani, Worcester, MA (US);
Kevin P. Cusack, Holden, MA (US);
Richard W. Dixon, Jefferson, MA (US);
Thomas D. Gordon, Medway, MA (US);
Kelly D. Mullen, Charlton, MA (US);
Robert V. Talanian, Harvard, MA (US);
Xiaoyun Wu, Westborough, MA (US);
Xiaolei Zhang, Ashland, MA (US);
Lu Wang, Northborough, MA (US);
Biqin Li, Northborough, MA (US);
Claude E. Barberis, Hillsborough, NJ (US);
Neil Wishart, Jefferson, MA (US);
Other;
Abstract
Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.